Pearl has commercially launched Second Opinion 3D, its FDA‑cleared AI solution for CBCT scan analysis. Previously available only for specialists, this tool now serves general dentists. It auto‑interprets cone‑beam CT data, generates color‑coded visual findings and supports insurance‑ready documentation. The platform integrates with existing 2D‑radiograph AI systems. Developers note AI acts only as diagnostic assistance rather than a replacement for clinician judgment. Widespread adoption may lower barriers for small‑size clinics to process complex 3D imaging and improve communication with patients.
FDA‑Cleared CBCT‑AI Tool Opens For General Dental Practices
Sep 02, 2026
Leave a message
